OX124 FDA Approval Status
FDA Approved: No
Brand name: OX124
Generic name: naloxone
Company: Orexo AB
Treatment for: Opioid Overdose
OX124 (naloxone) is a high-dose nasal formulation of the approved opioid antagonist naloxone in development as a rescue medication for opioid overdose.
- OX124 is a high-dose, prescription naloxone product designed to reverse the effects of the most powerful synthetic opioids, such as fentanyl.
- OX124 is formulated using the amorphOX® drug delivery platform which allows for a faster onset of action and a higher bioavailability of naloxone.
Development timeline for OX124
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
